Koncen Overview
- Year Founded
-
2001

- Status
-
Private
- Employees
-
405

- Latest Deal Type
-
IPO
- (Cancelled)
- Investors
-
4
Koncen General Information
Description
Developer of medical technology intended to offer blood-purification. The company's technology helps to accelerate blood dialysis and blood purification adsorption, enabling healthcare providers to save the lives of the patients.
Contact Information
Website
www.koncen.comCorporate Office
- No. 8 Shenzhou Street, Science City
- High-tech Industrial Development Zone
- Guangzhou, Guangdong 510660
- China
Corporate Office
- No. 8 Shenzhou Street, Science City
- High-tech Industrial Development Zone
- Guangzhou, Guangdong 510660
- China
Koncen Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. IPO | 11-Jul-2024 | Cancelled | Generating Revenue | |||
4. Secondary Transaction - Private | 28-May-2019 | Completed | Generating Revenue | |||
3. Later Stage VC | 29-Mar-2018 | Completed | Generating Revenue | |||
2. Later Stage VC | 01-Jan-2013 | $66.5K | Completed | Generating Revenue | ||
1. Seed Round | 18-Jul-2001 | $66.5K | $66.5K | Completed | Startup |
Koncen Patents
Koncen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4331701-A1 | Modified macroporous adsorption resin, preparation method therefor and use thereof | Pending | 28-May-2021 | ||
EP-4331701-A4 | Modified macroporous adsorption resin, preparation method therefor and use thereof | Pending | 28-May-2021 | ||
EP-4074733-A1 | Immunoglobulin binding protein, preparation method and application thereof | Pending | 06-Dec-2019 | ||
EP-4074733-A4 | Immunoglobulin binding protein, preparation method and application thereof | Pending | 06-Dec-2019 | ||
EP-3919097-A1 | Encapsulation structure of blood plasma adsorber and adsorbent thereof | Active | 29-Jan-2019 | A61M1/38 |
Koncen Signals
Koncen Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Hongshan Capital Group | Venture Capital | Minority | ||
Hyfinity Investments | Venture Capital | Minority | ||
Wens Investment (Guangdong) | Corporate Venture Capital | Minority | ||
Guangzhou Financial Innovation Investment | Venture Capital | Minority |
Koncen FAQs
-
When was Koncen founded?
Koncen was founded in 2001.
-
Where is Koncen headquartered?
Koncen is headquartered in Guangzhou, China.
-
What is the size of Koncen?
Koncen has 405 total employees.
-
What industry is Koncen in?
Koncen’s primary industry is Biotechnology.
-
Is Koncen a private or public company?
Koncen is a Private company.
-
What is Koncen’s current revenue?
The current revenue for Koncen is
. -
How much funding has Koncen raised over time?
Koncen has raised $66.5K.
-
Who are Koncen’s investors?
Hongshan Capital Group, Hyfinity Investments, Wens Investment (Guangdong), and Guangzhou Financial Innovation Investment have invested in Koncen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »